Truist starts IBM at Hold, says AI demand timing is the key question
Truist initiated coverage of IBM with a Hold rating and $240 price target, citing long-term potential in enterprise computing but near-term execution risks. IBM's Q2 miss was attributed to timing and budget shifts, leading to a 20% stock drop. Software revenue grew 8%, but deferred contracts impacted guidance. Analysts see upside potential if deferred deals close and software growth improves.
How this was made
The 30-second read
Why it matters
The guidance downgrade is a fresh, material fact for IBM, likely prompting further downside as investors reassess growth expectations.
Market read
IBM's stock already fell >20% pre‑market; the new guidance and coverage are likely to sustain bearish sentiment in the short term.
What to watch
IBM's strong free‑cash‑flow margin and recurring revenue base may cushion earnings volatility.
Background
Truist Securities released a new research note on IBM, initiating coverage with a Hold rating and a $240 price target, while cutting FY guidance amid concerns over AI spending timing.
Ticker impact
Truist initiates coverage at Hold, cuts IBM's full‑year constant‑currency revenue growth guidance to 4‑5% and sets a $240 price target; shares fell >20% pre‑market.
likely further pressure as the market prices in weaker guidance and execution concerns
The guidance cut is a primary, material disclosure for a large‑cap; the stock already dropped >20% and the price target is below current levels, indicating bearish bias.
Market effects
May weigh on broader enterprise‑software and mainframe vendors as AI spending timing is questioned.
Primarily U.S. market impact; limited immediate effect on overseas peers.
Highlights execution risk for AI‑focused hardware/software providers worldwide.
Counterpoint
If IBM can close deferred contracts and accelerate software growth, the stock could rebound despite short‑term pressure.
Key entities
- companyIBM
U.S.-listed technology and consulting firm.
- research_firmTruist Securities
Investment bank providing the coverage note.
